Cerity Partners LLC Has $1.79 Million Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

Cerity Partners LLC raised its position in ICU Medical, Inc. (NASDAQ:ICUI) by 33.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,846 shares of the medical instruments supplier’s stock after acquiring an additional 2,454 shares during the period. Cerity Partners LLC’s holdings in ICU Medical were worth $1,794,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ICUI. Innealta Capital LLC acquired a new stake in shares of ICU Medical during the second quarter worth approximately $32,000. Hexagon Capital Partners LLC grew its position in shares of ICU Medical by 162.7% during the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 122 shares during the period. Allworth Financial LP grew its holdings in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 100 shares during the period. Venturi Wealth Management LLC raised its stake in ICU Medical by 1,510.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 302 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of ICU Medical during the 2nd quarter valued at about $70,000. 96.10% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, Director David C. Greenberg sold 972 shares of the stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the transaction, the director now directly owns 5,037 shares in the company, valued at approximately $796,400.07. This represents a 16.18 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Vivek Jain sold 12,000 shares of the stock in a transaction on Friday, November 1st. The shares were sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $17,973,261.12. This represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,364 shares of company stock valued at $6,869,878. 6.70% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on ICUI shares. KeyCorp lifted their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Jefferies Financial Group started coverage on shares of ICU Medical in a research report on Monday, October 14th. They issued a “hold” rating and a $183.00 target price for the company. Finally, Raymond James increased their price target on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, ICU Medical currently has an average rating of “Moderate Buy” and an average price target of $173.00.

ICU Medical Stock Performance

NASDAQ ICUI opened at $160.96 on Tuesday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm has a market cap of $3.94 billion, a price-to-earnings ratio of -35.22 and a beta of 0.66. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26. The company has a fifty day moving average price of $174.60 and a 200-day moving average price of $147.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.